You are here : health.am > Health Centers > Drug News

Drug News

It’s time to consider propranolol as an anti-cancer drug, researchers say
• Cancer • • Drug News • Oct 13 16

It's time to consider propranolol as an anti-cancer drug, researchers say

Propranolol, a beta-blocker commonly prescribed to treat irregular heart rates and other conditions, has significant anti-cancer properties, say researchers in a new clinical study… It’s time to consider propranolol as an anti-cancer drug, researchers say   

 
 

Developing the tools to find new generation antibiotics
• Drug News • • Infections • Oct 15 15

Developing the tools to find new generation antibiotics

Scientists at the University of York have taken an important step in the search to find new antibiotics that are effective against resistant bacteria.

… Developing the tools to find new generation antibiotics   
 
 

Diabetes drug may reduce heart attack risk in HIV patients
• AIDS/HIV • • Drug News • • Heart • May 14 15

Diabetes drug may reduce heart attack risk in HIV patients

In patients with HIV, a diabetes drug may have benefits beyond lowering blood sugar. A new study from researchers at Washington University School of… Diabetes drug may reduce heart attack risk in HIV patients   

 
 

U of M institute discovers how aspirin fights cancer
• Cancer • • Drug News • Apr 30 15

U of M institute discovers how aspirin fights cancer

Taking aspirin reduces a person’s risk of colorectal cancer, but the molecular mechanisms involved have remained unknown until a recent discovery by The… U of M institute discovers how aspirin fights cancer   

 
 

New Waldenstrom’s drug shows sustained benefit at two years
• Cancer • • Drug News • Apr 09 15

New Waldenstrom's drug shows sustained benefit at two years

The most recent results from a clinical trial show that ibrutinib, a newly approved drug for Waldenstrom’s Macroglobulinemia, continued to control the rare blood… New Waldenstrom’s drug shows sustained benefit at two years   

 
 

Taking immunosuppressives, anti-cancer drugs may reactivate hepatitis B
• Cancer • • Drug News • • Infections • Feb 05 15

Taking immunosuppressives, anti-cancer drugs may reactivate hepatitis B

Individuals previously infected with the hepatitis B virus (HBV) who receive chemotherapy or immunosuppressive treatment may be at risk of reactivating the disease according… Taking immunosuppressives, anti-cancer drugs may reactivate hepatitis B   

 
 

Anti-epilepsy drug preserves brain function after stroke
• Drug News • • Stroke • Feb 04 15

Anti-epilepsy drug preserves brain function after stroke

New research suggests that an already-approved drug could dramatically reduce the debilitating impact of strokes, which affect nearly a million Americans every year.

In… Anti-epilepsy drug preserves brain function after stroke   

 
 

Researchers make breakthrough on new anesthetics
• Drug News • • Pain • Jan 20 15

Researchers make breakthrough on new anesthetics

For the first time since the 1970s, researchers are on the verge of developing a new class of anesthetics. According to a study published… Researchers make breakthrough on new anesthetics   

 
 

Improved mouse model will accelerate research on potential Ebola vaccines, treatments
• Drug News • • Infections • Nov 02 14

Improved mouse model will accelerate research on potential Ebola vaccines, treatments

In the war against Ebola one important hurdle has just been cleared – by a mouse.

Researchers at the University of North Carolina at… Improved mouse model will accelerate research on potential Ebola vaccines, treatments   

 
 

Bristol-Myers pulls U.S. marketing application for hepatitis C treatment
• Drug News • • Infections • Oct 07 14

Bristol-Myers pulls U.S. marketing application for hepatitis C treatment

Bristol-Myers Squibb said it withdrew its U.S. marketing application for an oral drug combination to treat hepatitis C, citing a “rapidly evolving” treatment landscape… Bristol-Myers pulls U.S. marketing application for hepatitis C treatment   

 
 

New cancer drug target involving lipid chemical messengers
• Cancer • • Drug News • Sep 21 14

New cancer drug target involving lipid chemical messengers

More than half of human cancers have abnormally upregulated chemical signals related to lipid metabolism, yet how these signals are controlled during tumor formation… New cancer drug target involving lipid chemical messengers   

 
 

Improving Medicines for Children in Canada
• Children's Health • • Drug News • Sep 18 14

Improving Medicines for Children in Canada'

Due to concerns about their vulnerability, children have historically been neglected in drug research and development, including clinical trials. But the reality is that… Improving Medicines for Children in Canada   

 
 

Xarelto Safe for Cardioverting Afib
• Drug News • • Heart • Sep 03 14

Xarelto Safe for Cardioverting Afib

Cardiologists who have switched atrial fibrillation patients awaiting elective cardioversion to a novel oral anticoagulant (NOAC) such as rivaroxaban (Xarelto) may find reassurance… Xarelto Safe for Cardioverting Afib   

 
 

Aspirin may reduce the risks of reoccurring blood clots
• Drug News • • Stroke • Aug 26 14

Aspirin may reduce the risks of reoccurring blood clots

Aspirin may be a promising alternative for those who can’t take long-term anticoagulant drugs that prevent clots from reoccurring in the veins, according… Aspirin may reduce the risks of reoccurring blood clots   

 
 

Roche to buy U.S. biotech firm InterMune for $8.3 billion
• Drug News • Aug 25 14

Roche to buy U.S. biotech firm InterMune for $8.3 billion

Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in… Roche to buy U.S. biotech firm InterMune for $8.3 billion   

 
 

Corcept shares slump after depression drug trial stopped
• Drug News • • Psychiatry / Psychology • May 08 14

Corcept shares slump after dePression drug trial stopped

Corcept Therapeutics Inc lost more than half its market value after the company said it would stop a late-stage trial of its depression drug… Corcept shares slump after depression drug trial stopped   

 
 

UnitedHealth: New hepatitis C drug costs far more than forecast
• Drug News • Apr 17 14

New hepatitis C drug costs far more than forecast

UnitedHealth Group Inc, the largest U.S. health insurer, said it spent more than $100 million to cover a pricey new hepatitis C drug… UnitedHealth: New hepatitis C drug costs far more than forecast   

 
 

FDA chief defends new pain drug despite worries about abuse
• Drug News • • Pain • Mar 13 14

FDA chief defends new pain drug despite worries about abuse

The head of the Food and Drug Administration on Thursday defended the agency’s approval of Zohydro, a powerful prescription opioid made by Zogenix Inc,… FDA chief defends new pain drug despite worries about abuse   

 
 

Children’s Mercy physician leads effort to update AAP policy
• Children's Health • • Drug News • Feb 23 14

Children's Mercy physician leads effort to update AAP policy

With less than half of medications including specific labeling for children, Kathleen Neville, MD, MS, a physician at Children’s Mercy Hospital, recently led an… Children’s Mercy physician leads effort to update AAP policy   

 
 

Breast cancer drug fights fungal disease
• Drug News • • Infections • Feb 11 14

Breast cancer drug fights fungal disease

Tamoxifen, a drug currently used to treat breast cancer, also kills a fungus that causes a deadly brain infection in immunocompromised patients. The findings,… Breast cancer drug fights fungal disease   

 
 

U.S. FDA approves Vanda’s circadian rhythm drug Hetlioz
• Drug News • Feb 01 14

U.S. FDA approves Vanda's circadian rhythm drug Hetlioz

Vanda Pharmaceuticals Inc said on Friday that U.S. health regulators have approved its experimental drug to regulate the internal body clocks of blind… U.S. FDA approves Vanda’s circadian rhythm drug Hetlioz   

 
 

Roche’s Tamiflu for children temporarily in short supply in U.S.
• Children's Health • • Drug News • Jan 10 14

Roche's Tamiflu for children temporarily in short supply in U.S.

In what is shaping up to be a tough and widespread flu season in the United States, one of the leading medicines used to… Roche’s Tamiflu for children temporarily in short supply in U.S.   

 
 

Building a better malaria vaccine: Mixing the right cocktail
• Drug News • • Infections • Dec 26 13

Building a better malaria vaccine: Mixing the right cocktail

A safe and effective malaria vaccine is high on the wish list of most people concerned with global health. Results published on December 26… Building a better malaria vaccine: Mixing the right cocktail   

 
 

Agenus genital herpes vaccine succeeds in mid-stage trial
• Drug News • Nov 07 13

Agenus genital herPes vaccine succeeds in mid-stage trial

Agenus Inc said a trial of its experimental genital herpes vaccine reduced the rate at which patients released the virus, reducing the likelihood… Agenus genital herpes vaccine succeeds in mid-stage trial   

 
 

Temple researchers uncover clues to how existing heart drugs work
• Drug News • • Heart • Nov 05 13

Temple researchers uncover clues to how existing heart drugs work

Some of the most commonly prescribed drugs for the treatment of heart failure are beta-blockers and nitrates, which help to relax blood vessels… Temple researchers uncover clues to how existing heart drugs work   

 
 
Page 1 of 26 pages  1 2 3 >  Last »

<< Back to main